AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)
Appeals Court Affirms Validity of Patent Expiring in 2028 THOUSAND OAKS, Calif., April 19, 2023 /PRNewswire/ -- Amgen today announced that the U.S. Court of Appeals for the Federal Circuit has... | June 19, 2023
Source: marketscreener.com